Title
a. Authorize the Interim Chief Executive Officer for Natividad Medical Center (NMC) or his designee to execute amendment No. 1 to the agreement (A-14125) with Monarch Medical Technologies, LLC. for glucose management system enterprise software subscription services, extending the agreement an additional forty (40) month period (October 1, 2021 through January 31, 2025) for a revised full agreement term of October 1, 2018 through January 31, 2025, and adding $87,026 for a revised total agreement amount not to exceed $277,041.
b. Authorize the Interim Chief Executive Officer or his designee to execute up to three (3) future amendments to the agreement which do not significantly alter the scope of work and do not cause an increase of more than then percent (10%) ($19,001) of the original cost of the agreement.
Report
RECOMMENDATION:
It is recommended the Board of Supervisors:
a. Authorize the Interim Chief Executive Officer for Natividad Medical Center (NMC) or his designee to execute amendment No. 1 to the agreement (A-14125) with Monarch Medical Technologies, LLC. for glucose management system enterprise software subscription services, extending the agreement an additional forty (40) month period (October 1, 2021 through January 31, 2025) for a revised full agreement term of October 1, 2018 through January 31, 2025, and adding $87,026 for a revised total agreement amount not to exceed $277,041.
b. Authorize the Interim Chief Executive Officer or his designee to execute up to three (3) future amendments to the agreement which do not significantly alter the scope of work and do not cause an increase of more than then percent (10%) ($19,001) of the original cost of the agreement.
SUMMARY/DISCUSSION:
Endotool is a clinical decision support software that provides personalized recommendations for insulin therapy to better control the patient's glycemic rates in a more automated fashion. Instead of the provider choosing from multiple order sets, it gives...
Click here for full text